OraCAb

N/A

Report date: 2025/03/20 09:34:17

Base Information

Drug NameOraCAb
Drug Alias NameClostridium difficile toxin A/B inhibiting polyclonal antibodies (MicroPharm)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionToxin A inhibitorsToxin B inhibitors
TargetsToxin AToxin B
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMicropharm
China Registration ClassN/A

Develop Information

Active CompaniesMicropharm
Inactive CompaniesN/A
Active IndicationsClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A